[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DK3256483T3 - Hidtil ukendt c-3-triterpenon med omvendte c-17-amidderivater som hiv-hæmmere patentkrav - Google Patents

Hidtil ukendt c-3-triterpenon med omvendte c-17-amidderivater som hiv-hæmmere patentkrav Download PDF

Info

Publication number
DK3256483T3
DK3256483T3 DK16784277.2T DK16784277T DK3256483T3 DK 3256483 T3 DK3256483 T3 DK 3256483T3 DK 16784277 T DK16784277 T DK 16784277T DK 3256483 T3 DK3256483 T3 DK 3256483T3
Authority
DK
Denmark
Prior art keywords
triterpenon
unknown
reverse
amide derivatives
hiv inhibitors
Prior art date
Application number
DK16784277.2T
Other languages
English (en)
Inventor
Reddy Bandi Parthasaradhi
Krupadanam Gazula Levi David
Reddy Adulla Panduranga
Reddy Kasireddy Bhaskar
Subrahmanyam Lanka Vl
Reddy Kura Rathnakar
Original Assignee
Hetero Labs Ltd
Dfh Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=57153504&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK3256483(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hetero Labs Ltd, Dfh Therapeutics Inc filed Critical Hetero Labs Ltd
Application granted granted Critical
Publication of DK3256483T3 publication Critical patent/DK3256483T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK16784277.2T 2015-02-09 2016-02-09 Hidtil ukendt c-3-triterpenon med omvendte c-17-amidderivater som hiv-hæmmere patentkrav DK3256483T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN623CH2015 2015-02-09
PCT/IB2016/000811 WO2016178092A2 (en) 2015-02-09 2016-02-09 C-3 novel triterpenone with c-28 reverse amide derivatives as hiv inhibitors

Publications (1)

Publication Number Publication Date
DK3256483T3 true DK3256483T3 (da) 2020-03-23

Family

ID=57153504

Family Applications (1)

Application Number Title Priority Date Filing Date
DK16784277.2T DK3256483T3 (da) 2015-02-09 2016-02-09 Hidtil ukendt c-3-triterpenon med omvendte c-17-amidderivater som hiv-hæmmere patentkrav

Country Status (22)

Country Link
US (3) US20170008921A1 (da)
EP (1) EP3256483B1 (da)
JP (1) JP2018505216A (da)
KR (1) KR20170110143A (da)
CN (1) CN107428797A (da)
AU (1) AU2016258274B2 (da)
BR (1) BR112017017109A2 (da)
CA (1) CA2975359A1 (da)
CL (1) CL2017002034A1 (da)
CO (1) CO2017008765A2 (da)
CU (1) CU24476B1 (da)
DK (1) DK3256483T3 (da)
EA (1) EA033264B1 (da)
ES (1) ES2780649T3 (da)
IL (1) IL253844A0 (da)
MA (1) MA40886B1 (da)
MX (1) MX2017010297A (da)
PE (1) PE20171433A1 (da)
PH (1) PH12017550077A1 (da)
SG (1) SG11201706189PA (da)
WO (1) WO2016178092A2 (da)
ZA (1) ZA201705253B (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170129916A1 (en) 2014-06-26 2017-05-11 Hetero Research Foundation Novel betulinic proline imidazole derivatives as hiv inhibitors
MA40886B1 (fr) 2015-02-09 2020-03-31 Hetero Research Foundation Nouveau triterpénone en c-3 avec des dérivés d'amide inverse en c-28 en tant qu'inhibiteurs du vih
WO2016147099A2 (en) * 2015-03-16 2016-09-22 Hetero Research Foundation C-3 novel triterpenone with c-28 amide derivatives as hiv inhibitors
AR107512A1 (es) 2016-02-04 2018-05-09 VIIV HEALTHCARE UK Nº 5 LTD Triterpenoides modificados en c-3 y c-17 como inhibidores del vih-1
WO2018029604A1 (en) * 2016-08-08 2018-02-15 Hetero Labs Limited C-3 novel triterpenone with c-17 reverse amide derivatives as hiv inhibitors
WO2019150300A1 (en) 2018-02-02 2019-08-08 Glaxosmithkline Intellectual Property (No.2) Limited Crystalline forms of 4-(((3ar,5ar,5br,7ar,9s,11ar,11br,13as)-3a-((r)-2-((4-chlorobenzyl)(2-(dimethylamino)ethyl)amino)-1-hydroxyethyl)-1-isopropyl-5a,5b,8,8,11a-pentamethyl-2-oxo-3,3a,4,5,5a,5b,6,7,7a,8,9,10,11,11a,11b,12,13,13a-octadecahydro-2h-cyclopenta[a]chrysen-9-yl)oxy)-2,2-dimethyl-4-oxobutanoic acid
CN109705189B (zh) * 2018-12-29 2020-06-05 中国医学科学院药用植物研究所 具有式i所示结构的三萜衍生物及其制备方法和应用
EP3924362A4 (en) * 2019-02-11 2022-10-26 Hetero Labs Limited NEW TRITERPENONE DERIVATIVES AS HIV Inhibitors

Family Cites Families (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58152815A (ja) 1982-03-05 1983-09-10 Tamio Nishimura 医療用抗ウイルス剤
CA2165188A1 (en) 1993-07-09 1995-01-19 Neal A. Deluca Selection and use of antiviral peptides
US5679828A (en) 1995-06-05 1997-10-21 Biotech Research Labs, Inc. Betulinic acid and dihydrobetulinic acid derivatives and uses therefor
WO1998046238A1 (en) 1997-04-15 1998-10-22 Medichem Research, Inc. Biflavinoids and derivatives thereof as antiviral agents, alone or in combination with at least one known antiviral agent
HUP9701080A3 (en) 1997-06-23 1999-05-28 Gene Res Lab Inc New York N Pharmaceutical composition containing a compound of antiviral activity and a hydroximic acid ester derivative
US6670345B1 (en) 1997-09-30 2003-12-30 Dabur Research Foundation Betulinic acid derivatives for inhabiting cancer growth and process for the manufacture of betulinic acid
US6427248B1 (en) 1997-10-09 2002-08-06 David M. Albert Grip-enhancing glove
CN1326462A (zh) 1998-11-18 2001-12-12 达布尔研究基金会 新的桦木酸衍生物,所述衍生物的制备方法以及它们作为癌症生长抑制剂的应用
WO2001007646A2 (de) 1999-07-21 2001-02-01 Martin Heinkelein Verfahren zur quantifizierung der antiviralen wirkung antiviraler wirkstoffe
DE69917684T2 (de) 1999-09-09 2005-07-21 Dabur Research Foundation, Sahibabad Betulinsäure-derivate mit antiangiogener wirkung, verfahren zur herstellung solcher derivate und deren verwendung für die behandlung tumorassoziierter angiogenese
CA2446748C (en) 2001-05-11 2011-03-08 University Of Ottawa Anxiolytic marcgraviaceae compositions containing betulinic acid, betulinic acid derivatives, and methods
WO2003037908A1 (en) 2001-10-31 2003-05-08 Ribapharm Inc. Antiviral combination therapy and compositions
EP1594885B8 (de) 2003-02-11 2009-03-25 Novelix Pharmaceuticals, Inc. Medikament zur wachstumsinhibierung von tumoren
US7026305B2 (en) 2003-04-14 2006-04-11 Meharry Medical College Anti-HIV agents with dual sites of action
AU2005224260A1 (en) 2004-03-17 2005-09-29 Panacos Pharmaceuticals, Inc. Pharmaceuticals salts of 3-O-(3',3'-dimethylsuccinyl) betulinic acid
MX2007005129A (es) 2004-10-27 2007-09-11 Daiichi Sankyo Co Ltd Compuesto de benceno que tiene 2 o mas sustituyentes.
TW200628161A (en) 2004-11-12 2006-08-16 Panacos Pharmaceuticals Inc Novel betulin derivatives, preparation thereof and use thereof
EP1869063A2 (en) 2005-03-29 2007-12-26 Regents Of The University Of Minnesota Methods of manufacturing bioactive 3-esters of betulinic aldehyde and betulinic acid
CA2609280A1 (en) 2005-06-22 2007-01-04 Myriad Genetics, Inc. Antiviral compounds
CN101287744A (zh) 2005-06-22 2008-10-15 美瑞德生物工程公司 抗病毒化合物
CN100475835C (zh) 2006-05-12 2009-04-08 中国药科大学 23-羟基白桦酸类衍生物、其制备方法、制剂及用途
FI121468B (fi) 2006-06-07 2010-11-30 Valtion Teknillinen Betuliiniperäiset yhdisteet antimikrobisina aineina
FI20065389A (fi) 2006-06-07 2007-12-31 Valtion Teknillinen Betuliiniperäiset yhdisteet kasvien tuholaisten syönnin estäjinä
WO2008127364A2 (en) 2006-10-13 2008-10-23 Myriad Genetics, Inc. Antiviral compounds and use thereof
WO2008115281A2 (en) 2006-10-16 2008-09-25 Myriad Genetics, Inc. Compounds for treating viral infections
AR063546A1 (es) * 2006-11-03 2009-01-28 Panacos Pharmaceuticals Inc DERIVADOS DE TRITERPENO, METODOS PARA SU PREPARACION, COMPOSICIONES FARMACEUTICAS QUE LOS COMPRENDEN Y SU USO EN LA FABRICACION DE MEDICAMENTOS PARA EL TRATAMIENTO DE INFECCIoN POR EL VIRUS VIH.
US20110152229A1 (en) 2006-11-22 2011-06-23 Duke University Betulinic acid derivatives as anti-hiv agents
WO2008091532A1 (en) 2007-01-19 2008-07-31 Panacos Pharmaceuticals, Inc. Salts of 3-o-(3',3'-dimethylsuccinyl)betulinic acid and solid state forms thereof
CN101977924A (zh) 2008-01-03 2011-02-16 Viro化学制药公司 新的c-21-酮基羽扇烷衍生物、其制备方法和应用
AU2008342537A1 (en) * 2008-01-03 2009-07-09 Virochem Pharma Inc. Novel lupane derivatives
CA2714049A1 (en) 2008-02-14 2009-08-20 Virochem Pharma Inc. Novel 17.beta. lupane derivatives
US8431556B2 (en) 2008-03-26 2013-04-30 Vertex Pharmaceuticals Incorporated C-21-keto lupane derivatives preparation and use thereof
WO2010132334A1 (en) 2009-05-15 2010-11-18 The University Of North Carolina At Chapel Hill 3,28-disubstituted betulinic acid derivatives as anti-hiv agents
US8802727B2 (en) 2009-07-14 2014-08-12 Hetero Research Foundation, Hetero Drugs Limited Pharmaceutically acceptable salts of betulinic acid derivatives
US9067966B2 (en) 2009-07-14 2015-06-30 Hetero Research Foundation, Hetero Drugs Ltd. Lupeol-type triterpene derivatives as antivirals
WO2011100308A1 (en) 2010-02-11 2011-08-18 Glaxosmithkline Llc Derivatives of betulin
MX2012013628A (es) 2010-06-04 2012-12-17 Bristol Myers Squibb Co Amidas c-28 de derivados del acido betulinico c-3 modificados como inhibidores de la maduracion del virus de inmunodeficiencia humana (vih).
BR112012030818A2 (pt) 2010-06-04 2019-09-24 Bristol-Myers Squibb Company "derivados de ácido c-3 betulínico modificado como inibidores da maturação do hiv"
WO2012095705A1 (en) 2011-01-10 2012-07-19 Hetero Research Foundation Pharmaceutically acceptable salts of novel betulinic acid derivatives
CN103620621B (zh) 2011-06-30 2017-10-24 诺基亚技术有限公司 用于利用积分梯度投影的面部跟踪的方法和装置
WO2013020245A1 (en) 2011-08-08 2013-02-14 Glaxosmithkline Llc Carbonyl derivatives of betulin
JP6091520B2 (ja) 2011-12-14 2017-03-08 グラクソスミスクライン エルエルシー ベツリンのプロペン酸誘導体
WO2013091144A1 (en) 2011-12-21 2013-06-27 Glaxosmithkline Llc Propenoate derivatives of betulin
JO3387B1 (ar) 2011-12-16 2019-03-13 Glaxosmithkline Llc مشتقات بيتولين
CN103242413B (zh) * 2012-02-08 2015-08-26 江西青峰药业有限公司 Lupane三萜系衍生物及其药学用途
WO2013160810A2 (en) 2012-04-24 2013-10-31 Hetero Research Foundation Novel betulinic acid derivatives as hiv inhibitors
EP2931285A4 (en) 2012-12-14 2016-06-01 Glaxosmithkline Llc PHARMACEUTICAL COMPOSITIONS
WO2014105926A1 (en) 2012-12-31 2014-07-03 Hetero Research Foundation Novel betulinic acid proline derivatives as hiv inhibitors
US20170129916A1 (en) 2014-06-26 2017-05-11 Hetero Research Foundation Novel betulinic proline imidazole derivatives as hiv inhibitors
WO2015198263A2 (en) 2014-06-26 2015-12-30 Hetero Research Foundation Novel betulinic proline substituted derivatives as hiv inhibitors
MA40886B1 (fr) 2015-02-09 2020-03-31 Hetero Research Foundation Nouveau triterpénone en c-3 avec des dérivés d'amide inverse en c-28 en tant qu'inhibiteurs du vih
WO2016147099A2 (en) 2015-03-16 2016-09-22 Hetero Research Foundation C-3 novel triterpenone with c-28 amide derivatives as hiv inhibitors
WO2017017630A1 (en) 2015-07-28 2017-02-02 Hetero Research Foundation Novel betulinic substituted amide derivatives as hiv inhibitors
WO2017021922A1 (en) 2015-08-05 2017-02-09 Hetero Research Foundation Novel substituted amides of triterpene derivatives as hiv inhibitors
WO2017064628A1 (en) 2015-10-13 2017-04-20 Hetero Research Foundation C-3 novel triterpenone with c-28 urea derivatives as hiv inhibitors
WO2017115329A1 (en) 2015-12-30 2017-07-06 Hetero Research Foundation C-3 novel triterpenone derivatives as hiv inhibitors
WO2017149518A1 (en) 2016-03-04 2017-09-08 Hetero Labs Limited C-3 novel triterpene with c-17 amine derivatives as hiv inhibitors
WO2018025247A1 (en) 2016-08-05 2018-02-08 Hetero Labs Limited C-3 novel triterpenone with c-28 diamide derivatives as hiv inhibitors
WO2018029604A1 (en) 2016-08-08 2018-02-15 Hetero Labs Limited C-3 novel triterpenone with c-17 reverse amide derivatives as hiv inhibitors
WO2018029602A1 (en) 2016-08-08 2018-02-15 Hetero Labs Limited C-3 novel triterpenone with c-28 heterocycle derivatives as hiv inhibitors
WO2018029610A1 (en) 2016-08-09 2018-02-15 Hetero Labs Limited C-3 novel triterpenone with c-17 n-amide derivatives as hiv inhibitors
US20180097839A1 (en) 2016-10-01 2018-04-05 Neeraj S. Upasani Systems, apparatuses, and methods for platform security
WO2018069857A1 (en) 2016-10-12 2018-04-19 Hetero Labs Limited C-3 novel triterpenone with c-17 reverse amide heterocycle derivatives as hiv inhibitors

Also Published As

Publication number Publication date
JP2018505216A (ja) 2018-02-22
WO2016178092A8 (en) 2017-09-21
ES2780649T3 (es) 2020-08-26
KR20170110143A (ko) 2017-10-10
AU2016258274A1 (en) 2017-09-07
US20200087342A1 (en) 2020-03-19
EA201791807A1 (ru) 2018-01-31
EP3256483B1 (en) 2019-12-11
SG11201706189PA (en) 2017-08-30
US11034718B2 (en) 2021-06-15
BR112017017109A2 (pt) 2018-04-03
WO2016178092A2 (en) 2016-11-10
CU20170102A7 (es) 2018-01-10
WO2016178092A3 (en) 2017-01-05
CL2017002034A1 (es) 2018-04-27
US20170008921A1 (en) 2017-01-12
PE20171433A1 (es) 2017-09-26
US20180215780A1 (en) 2018-08-02
CA2975359A1 (en) 2016-11-10
EA033264B1 (ru) 2019-09-30
PH12017550077A1 (en) 2018-02-12
AU2016258274B2 (en) 2019-12-05
CN107428797A (zh) 2017-12-01
MA40886B1 (fr) 2020-03-31
US10533035B2 (en) 2020-01-14
CU24476B1 (es) 2020-03-04
MX2017010297A (es) 2018-11-12
EP3256483A2 (en) 2017-12-20
IL253844A0 (en) 2017-09-28
CO2017008765A2 (es) 2017-11-10
ZA201705253B (en) 2020-01-29

Similar Documents

Publication Publication Date Title
DK3464271T3 (da) Pyrazolderivater som plasma-kallikreininhibitorer
DK3661921T3 (da) Selektive hæmmere af nlrp3-inflammasom
DK3277677T3 (da) 1-cyano-pyrrolidinforbindelser som usp30-hæmmere
DK3324977T3 (da) Benzodiazepinderivater som rsv-inhibitorer
DK3371190T3 (da) Heterocykliske forbindelser som pi3k-gamma-inhibitorer
DK3580220T3 (da) Aminotriazolpyridiner som kinasehæmmere
DK3786162T3 (da) Bipyrazolderivater som jak-inhibitorer
DK3256483T3 (da) Hidtil ukendt c-3-triterpenon med omvendte c-17-amidderivater som hiv-hæmmere patentkrav
DK3271349T3 (da) Benzimidazolederivater som bromodomain-inhibitorer
DK3182962T3 (da) Compositions and uses of amidine derivatives
DK3348556T3 (da) Heteroarylamider som hæmmere af proteinaggregering
DK3389379T3 (da) Mikrobiocide phenylamidinderivater
DK3538528T3 (da) Pyrrolamider som alpha v-integrinhæmmere
DK3204378T6 (da) N-pyridinylacetamidderivater som hæmmere af wnt-signaleringsbanen
DK3777833T3 (da) Dopa-decarboxylase-inhibitorsammensætninger
MA43367A (fr) Inhibiteurs de métallo-bêta-lactamases
DK3544981T3 (da) Benzodiazoliumforbindelser som enac-inhibitorer
DK3704118T3 (da) Aminoimidazopyrazin som kinasehæmmere
DK3094322T3 (da) Administration af tasimelteon i fastende tilstand
DK3164123T3 (da) Hidtil ukendte anvendelser af benzylidenguanidinderivater til behandling af proteopatier
MA46280A (fr) Inhibiteurs de la dopamine-b-hydroxylase
DK3265057T3 (da) Topisk formulering
DK3227325T3 (da) Sammensætninger med selektive hæmmere af il-6-trans-signalering
DK3418273T3 (da) Derivater af flavagliner
DK3137658T3 (da) Anvendelse af kendte forbindelser som d-aminosyreoxidase-inhibitorer